Moderna (MRNA)

Operating Expenses

$3.04B

TTM · Period ending: · USD

MRNA logo

MRNA Operating Expenses

Latest reported$3.04B
MRNA TTM Operating Expenses ($454.64M → $3.04B)
High-resolution chart · PNG

MRNA operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
3,040,000,000
3,103,000,000
3,348,000,000
3,728,000,000
4,871,000,000
5,410,000,000
5,680,000,000
6,095,000,000
6,286,000,000
6,297,000,000
6,372,000,000
6,145,000,000
5,497,000,000
4,755,000,000
4,039,000,000
2,975,000,000
2,570,000,000
2,235,000,000
1,823,000,000
2,066,144,000
1,901,671,000
1,679,549,000
1,527,355,000
832,883,000
588,866,000
557,280,000
452,726,999
498,156,999
478,740,999
350,835,999
339,900,000
286,615,000
460,261,000
454,917,500
454,644,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.